DNTHDianthus TherapeuticsRunning, no new patients
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
Myasthenia Gravis, Generalized
10Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +10
Main results were due Jul 2025, none posted yet
Counts until it's fixed
Worry score10
Score over time
- Stage
- Phase 2
- Patients
- 65 (final count)
- Started
- Feb 23, 2024
- Main results expected
- Jul 28, 2025
- Fully finished
- Oct 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Incidence of Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (SAEs)
Measured over: Baseline (Day 1) to Week 13
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- results_overdue: base 10, now 10, since 2025-07-28, no fading
Raw record changes
- none yet
Trial ID NCT06282159 · record last updated 2026-07-27 · checked 2026-11-09 15:36 UTC